Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Nature Medicine|June 12, 2012
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistanceJustin M Balko, Rebecca S Cook, David B Vaught, et al.
Nature Biomedical Engineering|May 16, 2025
siRNA conjugate with high albumin affinity and degradation resistance for delivery and treatment of arthritis in mice and guinea pigsJuan M Colazo, Megan C Keech, Veeraj Shah, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Structural Optimization of siRNA Conjugates for Albumin Binding Achieves Effective MCL1-Targeted Cancer TherapyElla N Hoogenboezem, Shrusti S Patel, Ashley B Cavnar, et al.
Science Translational Medicine|April 15, 2016
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependenceJustin M Balko, Luis J Schwarz, Na Luo, et al.
Nature Communications|February 21, 2024
Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapyElla N Hoogenboezem, Shrusti S Patel, Justin H Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2015
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint InhibitorsSherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.
Journal of Medicinal Chemistry|April 2, 2019
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human CancerTaekyu Lee, Plamen P Christov, Subrata Shaw, et al.
Cancer Discovery|December 21, 2013
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targetsJustin M Balko, Jennifer M Giltnane, Kai Wang, et al.
Molecular & Cellular Proteomics : MCP|May 9, 2015
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast CancerChristian D Young, Lisa J Zimmerman, Daisuke Hoshino, et al.
Pageof 8